Published in N Engl J Med on March 25, 1999
Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960-98. BMJ (2003) 8.94
Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ (2004) 6.31
Constructing "sound science" and "good epidemiology": tobacco, lawyers, and public relations firms. Am J Public Health (2001) 4.21
Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ (2004) 3.66
Passive smoking, coronary heart disease, and meta-analysis. N Engl J Med (1999) 3.55
Declines in hospital admissions for acute myocardial infarction in New York state after implementation of a comprehensive smoking ban. Am J Public Health (2007) 2.52
Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect (2001) 2.38
Chimney stove intervention to reduce long-term wood smoke exposure lowers blood pressure among Guatemalan women. Environ Health Perspect (2007) 2.23
Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. Environ Health Perspect (1999) 2.11
Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. Am J Public Health (2004) 2.02
Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ (2010) 1.95
How acute and reversible are the cardiovascular risks of secondhand smoke? BMJ (2004) 1.68
Association between exposure to environmental tobacco smoke and the development of acute coronary syndromes: the CARDIO2000 case-control study. Tob Control (2002) 1.52
Disease burden of adult lung cancer and ischaemic heart disease from passive tobacco smoking in China. Tob Control (2007) 1.50
Intervention to lower household wood smoke exposure in Guatemala reduces ST-segment depression on electrocardiograms. Environ Health Perspect (2011) 1.49
Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res (2010) 1.45
Secondhand smoke exposure is associated with increased carotid artery intima-media thickness: the Bogalusa Heart Study. Atherosclerosis (2015) 1.43
Meta-analysis of the association between second-hand smoke exposure and ischaemic heart diseases, COPD and stroke. BMC Public Health (2015) 1.42
Passive smoking at work: the short-term cost. J Epidemiol Community Health (2000) 1.39
Passive smoking in the home: plasma cotinine concentrations in non-smokers with smoking partners. Tob Control (2001) 1.38
Environmental tobacco smoke and mortality in Chinese women who have never smoked: prospective cohort study. BMJ (2006) 1.34
The association between secondhand smoke and the risk of developing acute coronary syndromes, among non-smokers, under the presence of several cardiovascular risk factors: The CARDIO2000 case-control study. BMC Public Health (2002) 1.19
Association between clean indoor air laws and voluntary smokefree rules in homes and cars. Tob Control (2013) 1.19
Passive smoking and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. PLoS One (2013) 1.15
Science, politics, and ideology in the campaign against environmental tobacco smoke. Am J Public Health (2002) 1.10
Secondhand smoke (SHS) exposure is associated with circulating markers of inflammation and endothelial function in adult men and women. Atherosclerosis (2009) 1.10
Tobacco cessation in primary care: maximizing intervention strategies. Clin Med Res (2003) 1.09
Workplace smoking related absenteeism and productivity costs in Taiwan. Tob Control (2005) 1.08
Effects of passive smoking on blood pressure and aortic pressure waveform in healthy young adults--influence of gender. Br J Clin Pharmacol (2004) 1.07
Smoking in Saudi Arabia and its relation to coronary artery disease. J Saudi Heart Assoc (2009) 1.07
Environmental tobacco smoke and lung function in employees who never smoked: the Scottish MONICA study. Occup Environ Med (2001) 1.06
Environmental tobacco smoke and measures of subclinical vascular disease. Environ Health Perspect (1999) 1.06
The Quit Benefits Model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking. Cost Eff Resour Alloc (2007) 1.02
Cotinine-assessed second-hand smoke exposure and risk of cardiovascular disease in older adults. Heart (2010) 0.98
A guideline for perioperative smoking cessation. J Anesth (2017) 0.96
Barriers to adopting and implementing local-level tobacco control policies. J Community Health (2011) 0.96
Exposure to environmental tobacco smoke (ETS) and determinants of support for complete smoking bans in psychiatric settings. Tob Control (2004) 0.95
Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation. PLoS One (2012) 0.93
Mitochondrial oxidative stress significantly influences atherogenic risk and cytokine-induced oxidant production. Environ Health Perspect (2010) 0.92
Second-hand smoke exposure in Canada: prevalence, risk factors, and association with respiratory and cardiovascular diseases. Can Respir J (2008) 0.91
Strategies implemented by 20 local tobacco control agencies to promote smoke-free recreation areas, California, 2004-2007. Prev Chronic Dis (2011) 0.91
The impact of a 100% smoke-free law on the health of hospitality workers from the city of Neuquén, Argentina. Tob Control (2010) 0.90
Developmental exposure to second-hand smoke increases adult atherogenesis and alters mitochondrial DNA copy number and deletions in apoE(-/-) mice. PLoS One (2013) 0.88
Smoke-free laws, gender, and reduction in hospitalizations for acute myocardial infarction. Public Health Rep (2011) 0.88
Secondhand smoke exposure and smoking behavior among young adult bar patrons. Am J Public Health (2013) 0.88
Impact of a partial smoke-free legislation on myocardial infarction incidence, mortality and case-fatality in a population-based registry: the REGICOR Study. PLoS One (2013) 0.88
Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease. PLoS One (2013) 0.88
Changes in environmental tobacco smoke (ETS) exposure over a 20-year period: cross-sectional and longitudinal analyses. Addiction (2009) 0.88
Cigarette smoke and adverse health effects: An overview of research trends and future needs. Int J Angiol (2007) 0.87
Management standards for stable coronary artery disease in India. Indian Heart J (2016) 0.86
Association between exposure to environmental tobacco smoke and biomarkers of oxidative stress among patients hospitalised with acute myocardial infarction. PLoS One (2013) 0.86
Passive smoking and coronary heart disease. N Engl J Med (1999) 0.84
Active and passive smoking and the risk of myocardial infarction in 24,968 men and women during 11 year of follow-up: the Tromsø Study. Eur J Epidemiol (2013) 0.82
Acute respiratory and cardiovascular admissions after a public smoking ban in Geneva, Switzerland. PLoS One (2014) 0.82
A qualitative evaluation of 40 voluntary, smoke-free, multiunit, housing policy campaigns in California. Tob Control (2013) 0.81
Secondhand smoke exposure and endothelial stress in children and adolescents. Acad Pediatr (2014) 0.80
Partner's smoking status and acute coronary syndrome: population-based case-control study in Tirana, Albania. Croat Med J (2008) 0.80
Association between environmental tobacco smoke exposure and dementia syndromes. Occup Environ Med (2012) 0.79
The impact of smoke-free laws on asthma discharges: a multistate analysis. Am J Public Health (2013) 0.79
Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study. PLoS One (2016) 0.79
Quantification of ETS exposure in hospitality workers who have never smoked. Environ Health (2010) 0.78
Air nicotine monitoring for second hand smoke exposure in public places in India. Indian J Community Med (2011) 0.78
Chronic exposure to second hand smoke and 30-day prognosis of patients hospitalised with acute coronary syndromes: the Greek study of acute coronary syndromes. Heart (2007) 0.78
The Associations Between Smoking Habits and Serum Triglyceride or Hemoglobin A1c Levels Differ According to Visceral Fat Accumulation. J Epidemiol (2015) 0.78
Arterial Compliance and Autonomic Functions in Adult Male Smokers. J Clin Diagn Res (2016) 0.78
Are passive smoking, air pollution and obesity a greater mortality risk than major radiation incidents? BMC Public Health (2007) 0.77
Quality of systematic reviews of observational nontherapeutic studies. Prev Chronic Dis (2010) 0.77
Household secondhand smoke exposure of elementary schoolchildren in Southern Taiwan and factors associated with their confidence in avoiding exposure: a cross-sectional study. BMC Public Health (2012) 0.77
Lung cancer and passive smoking. Turning over the wrong stone. BMJ (2000) 0.75
A helpline telephone service for tobacco related issues: the Italian experience. Int J Environ Res Public Health (2009) 0.75
A meta-analysis of epidemiological studies on the relationship between occupational electromagnetic field exposure and the risk of adult leukemia. Environ Health Prev Med (2000) 0.75
Longitudinal Impact of the Smoking Ban Legislation in Acute Coronary Syndrome Admissions. Biomed Res Int (2017) 0.75
Passive smoking and coronary heart disease. N Engl J Med (1999) 0.75
Impact of Partial and Comprehensive Smoke-Free Regulations on Indoor Air Quality in Bars. Int J Environ Res Public Health (2016) 0.75
Association Between a Ban on Smoking in a Hospital and the In-Hospital Onset of Acute Myocardial Infarction. Cardiol Res (2015) 0.75
Passive smoking and coronary heart disease. N Engl J Med (1999) 0.75
Gene/Environment interaction in atherosclerosis: an example of clinical medicine as seen from the evolutionary perspective. Int J Hypertens (2010) 0.75
Cigarette Smoking and Oxidative Stress in Patients with Coronary Artery Disease. Open Access Maced J Med Sci (2016) 0.75
Management Protocols of stable coronary artery disease in India: Executive summary. Indian Heart J (2016) 0.75
Passive smoking and coronary heart disease. N Engl J Med (1999) 0.75
Smoking bans in mental health hospitals in Japan: barriers to implementation. Ann Gen Psychiatry (2015) 0.75
Assessment of nicotine for second hand smoke exposure in some public places in Romania by UPLC-MS. Chem Cent J (2014) 0.75
Tobacco and end stage renal disease: a multicenter, cross-sectional study in Argentinian Northern Patagonia. Tob Induc Dis (2015) 0.75
The Health Effects of Passive Smoking: An Overview of Systematic Reviews Based on Observational Epidemiological Evidence. PLoS One (2015) 0.75
Factors associated with secondhand smoke incursion into the homes of non-smoking residents in a multi-unit housing complex: a cross-sectional study in Seoul, Korea. BMC Public Health (2017) 0.75
The Relationship between Environmental Tobacco Smoke Exposure and Cardiovascular Disease and the Potential Modifying Effect of Diet in a Prospective Cohort among American Indians: The Strong Heart Study. Int J Environ Res Public Health (2017) 0.75
Smoking Behaviors in Kosova: Results of Steps Survey. Zdr Varst (2017) 0.75
Cardiovascular risk and dyslipidemia among persons living with HIV: a review. BMC Infect Dis (2017) 0.75
Relation between secondhand smoke exposure and cardiovascular risk factors in never smokers. J Hypertens (2017) 0.75
Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA (2000) 10.40
Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (1975) 10.33
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA (1999) 9.18
Endogenous opioid peptides: multiple agonists and receptors. Nature (1977) 8.21
Clinical and epidemiologic features of primary HIV infection. Ann Intern Med (1996) 6.04
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med (1997) 5.72
Blood pressure and end-stage renal disease in men. N Engl J Med (1996) 5.68
Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA (1998) 5.37
End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA (1997) 5.09
Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA (1992) 5.07
Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep (1998) 4.85
Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med (2001) 4.81
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens (1996) 4.66
Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med (1994) 4.64
The gene for familial polyposis coli maps to the long arm of chromosome 5. Science (1987) 4.48
Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol (1972) 4.45
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Br J Pharmacol (1972) 4.11
Hyponatraemia after orthopaedic surgery. BMJ (1999) 3.91
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA (1999) 3.85
Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Br J Pharmacol (1975) 3.76
The use of an optical brightener in the study of plant structure. Stain Technol (1975) 3.70
The association of skin color with blood pressure in US blacks with low socioeconomic status. JAMA (1991) 3.29
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol (2000) 3.27
Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res (1975) 3.26
Head and neck schwannomas--a 10 year review. J Laryngol Otol (2000) 3.25
The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA (1992) 3.01
Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension (2000) 3.01
Chronic conditions and risk of in-hospital death. Health Serv Res (1994) 3.00
Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia (2003) 3.00
Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol (1991) 2.89
Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ (1997) 2.87
Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med (1991) 2.74
Diabetes mellitus, race, and socioeconomic status. A population-based study. Ann Epidemiol (1996) 2.71
The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. Br J Pharmacol (1977) 2.59
Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med (1993) 2.55
Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension (2001) 2.42
Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J (1978) 2.41
Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials. Am J Clin Nutr (1991) 2.39
Evidence for a protein mutator in yeast: role of the Hsp70-related chaperone ssb in formation, stability, and toxicity of the [PSI] prion. Mol Cell Biol (1999) 2.37
Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome. Nat Genet (1994) 2.35
Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther (2015) 2.34
Undetected eye disease in a primary care clinic population. Arch Intern Med (1994) 2.32
Use of expiratory CT pulmonary angiography to reduce inspiration and breath-hold associated artefact: contrast dynamics and implications for scan protocol. Clin Radiol (2011) 2.30
Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br Med J (1979) 2.30
A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study. JAMA (1993) 2.25
Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem J (1980) 2.24
Errors in using tobacco withdrawal scale. Tob Control (1998) 2.23
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol (1971) 2.17
End-stage renal disease attributable to diabetes mellitus. Ann Intern Med (1994) 2.16
Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Intern Med (1995) 2.12
Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol (1999) 2.09
Osteopontin--a molecule for all seasons. QJM (2002) 2.09
Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. Arch Intern Med (2001) 2.08
Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci (1992) 2.06
Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA (1997) 2.06
Trends in pharmacologic management of hypertension in the United States. Arch Intern Med (1995) 2.04
A randomised controlled trial of the effect of the provision of free school milk on the growth of children. J Epidemiol Community Health (1980) 2.04
Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol (2001) 2.03
Selection of initial antihypertensive drug therapy. Lancet (2000) 2.02
The phototropin family of photoreceptors. Plant Cell (2001) 2.01
New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med (2000) 2.00
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98
A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr (2004) 1.97
Provision of home births. BMJ (1992) 1.96
Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension (2000) 1.96
Migration, blood pressure pattern, and hypertension: the Yi Migrant Study. Am J Epidemiol (1991) 1.94
A prokaryotic phytochrome. Nature (1997) 1.91
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A (1999) 1.89
beta 3: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. Proc Natl Acad Sci U S A (2000) 1.89
Purification and properties of enkephalin - the possible endogenous ligand for the morphine receptor. Life Sci (1975) 1.88
Depression after stroke and lesion location: a systematic review. Lancet (2000) 1.87
An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care (2005) 1.87
Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension (1980) 1.86
Influence of dose and fiber type on respiratory malignancy risk in asbestos cement manufacturing. Am Rev Respir Dis (1979) 1.85
Value of routine chest radiography of psychiatric patients. Br Med J (1980) 1.84
Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J (1999) 1.83
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol (1997) 1.82
A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis. Am J Surg (1991) 1.79
Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol (1998) 1.79
End-stage renal disease in US minority groups. Am J Kidney Dis (1992) 1.74
Incorporation of labelled amino acids into the enkephalins. FEBS Lett (1977) 1.73
Efficacy of a computerized local anesthesia device in pediatric dentistry. Pediatr Dent (2000) 1.72
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72
Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci (1975) 1.71
Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci U S A (2004) 1.69
Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study. Hypertension (2001) 1.68
On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J Antibiot (Tokyo) (1978) 1.67
Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med (1993) 1.65
Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium. Br J Pharmacol (1970) 1.64
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
Awareness, use, and impact of the 1984 Joint National Committee consensus report on high blood pressure. Am J Public Health (1988) 1.63
Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). NHP Investigative Team. Hypertension (1995) 1.62
Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol. Pediatr Pulmonol (2003) 1.61